Publications en collaboration avec des chercheurs de Pfizer (United States) (20)

2024

  1. Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients

    Clinical and Translational Oncology

  2. Prevalence of transthyretin cardiac amyloidosis in patients with heart failure with preserved ejection fraction: the PRACTICA study

    Revista Espanola de Cardiologia

  3. Use of digital health tools in inflammatory bowel disease

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 9

2023

  1. Management of Specific Clinical Profiles in Axial Spondyloarthritis: An Expert’s Document Based on a Systematic Literature Review and Extended Delphi Process

    Rheumatology and Therapy, Vol. 10, Núm. 5, pp. 1215-1240

  2. Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study

    Microorganisms, Vol. 11, Núm. 11

2022

  1. Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)

    Lung Cancer, Vol. 173, pp. 83-93

2021

  1. Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review

    Rheumatology and Therapy, Vol. 8, Núm. 1, pp. 17-40

2020

  1. The economic burden of metastatic breast cancer in Spain

    European Journal of Hospital Pharmacy , Vol. 27, Núm. 1, pp. 19-24

2019

  1. Report of a TREAT-NMD/World duchenne organisation meeting on dystrophin quantification methodology

    Journal of Neuromuscular Diseases

2017

  1. The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study

    Vaccine, Vol. 35, Núm. 39, pp. 5264-5270

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. Psychometric attributes of the Cervantes short-form questionnaire for measuring health-related quality of life in menopausal women

    Maturitas, Vol. 84, pp. 55-62

2013

  1. Microbial aetiology of healthcare associated pneumonia in Spain: A prospective, multicentre, case-control study

    Thorax, Vol. 68, Núm. 11, pp. 1007-1014

2008

  1. The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: Results from a two-year controlled prospective study

    Journal of Clinical Endocrinology and Metabolism, Vol. 93, Núm. 7, pp. 2709-2715

2007

  1. Impacto de la EPOC en la vida diaria de los pacientes. Resultados del estudio multicéntrico EIME

    Archivos de Bronconeumologia, Vol. 43, Núm. 2, pp. 64-72

2006

  1. Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: Potential implications for plaque stabilization

    Journal of Cardiovascular Pharmacology, Vol. 47, Núm. 1, pp. 60-69

  2. Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA

    Journal of Clinical Endocrinology and Metabolism, Vol. 91, Núm. 12, pp. 5038-5043

2005

  1. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month

    Stroke, Vol. 36, Núm. 8, pp. 1796-1800

1994

  1. Novel Series of Achiral, Low Molecular Weight, and Potent HIV-1 Protease Inhibitors

    Journal of the American Chemical Society, Vol. 116, Núm. 15, pp. 6989-6990